Shares of Adamis crater on CRL; Boris Johnson promises to double dementia research funding
→ San Diego-based Adamis $ADMP saw its shares crater on the news that the FDA has rejected its application to market high-dose naloxone injection …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
